The OS in HCC patients with a low expression of ACTG1, CSNK1D, PPP1CC, or BIRC5 was prolonged relative to patients with high expression of ACTG1, CSNK1D, PPP1CC, or BIRC5 (Figure 7(e)). Here, PPP1CC is linked to hepatocellular carcinoma.